Seelos Therapeutics jumps on grant for Parkinson's gene therapy

Seelos Therapeutics

24/08/2022 17:02

** Shares of Seelos Therapeutics Inc  SEEL.O  rise ~15% to
$1.19 
    ** Biopharmaceutical company to receive grant from The
Michael J. Fox Foundation for Parkinson's Research for its gene
therapy delivered SLS-004 program  urn:newsml:reuters.com:*:nPn7mxzcta
    ** Co did not provide details on the grant
    ** The Foundation is world's largest nonprofit funder of
Parkinson's research with $1.5 bln funding to date
    ** Including session's gain, stock down ~27% YTD

 (Reporting by Raghav Mahobe)
 ((Raghav.Mahobe@thomsonreuters.com;))